South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to develop and sell the biotech company's experimental Alzheimer's disease treat... ...